BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32336066)

  • 1. [Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
    Li G; Wang Y; Tan G; Liu Y; Xu Z; Feng H; Xing W; Xu Z
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):351-359. PubMed ID: 32336066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors.
    Cui S; Ni Y; Zhao Y; Li Z; Xiong L; Liu J; Liang X; Jiang L
    Lung Cancer; 2019 Jun; 132():45-53. PubMed ID: 31097093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres.
    Wang SG; Zhang B; Li CG; Zhu JQ; Sun BS; Wang CL
    Thorac Cancer; 2020 Oct; 11(10):2887-2895. PubMed ID: 32856417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer.
    Hsu CL; Tsai TH; Huang CK; Yang CY; Liao WY; Ho CC; Ruan SY; Chen KY; Shih JY; Yang PC
    Lung Cancer; 2021 Jun; 156():50-58. PubMed ID: 33894494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enumeration and Molecular Characterization of Circulating Tumor Cell Using an Epithelial Cell Adhesion Molecule/Vimentin/Epidermal Growth Factor Receptor Joint Capture System in Lung Cancer.
    Jiang W; Wu J; Lin X; Chen Z; Lin L; Yang J
    Clin Med Insights Oncol; 2024; 18():11795549241231568. PubMed ID: 38525298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Jiang T; Zhao J; Zhao C; Li X; Shen J; Zhou J; Ren S; Su C; Zhou C; O'Brien M
    Clin Lung Cancer; 2019 Mar; 20(2):124-133.e2. PubMed ID: 30587399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
    Mascalchi M; Falchini M; Maddau C; Salvianti F; Nistri M; Bertelli E; Sali L; Zuccherelli S; Vella A; Matucci M; Voltolini L; Pegna AL; Luconi M; Pinzani P; Pazzagli M
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):195-200. PubMed ID: 26210156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases.
    van Bussel MTJ; Pluim D; Milojkovic Kerklaan B; Bol M; Sikorska K; Linders DTC; van den Broek D; Beijnen JH; Schellens JHM; Brandsma D
    Neurology; 2020 Feb; 94(5):e521-e528. PubMed ID: 31907288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic Acid Targeting for Efficient Isolation and Detection of Ovarian Cancer CTCs from Human Whole Blood Based on Two-Step Binding Strategy.
    Nie L; Li F; Huang X; Aguilar ZP; Wang YA; Xiong Y; Fu F; Xu H
    ACS Appl Mater Interfaces; 2018 Apr; 10(16):14055-14062. PubMed ID: 29620849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cells.
    Sawada T; Watanabe M; Fujimura Y; Yagishita S; Shimoyama T; Maeda Y; Kanda S; Yunokawa M; Tamura K; Tamura T; Minami H; Koh Y; Koizumi F
    Cancer Sci; 2016 Mar; 107(3):307-14. PubMed ID: 26708016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.
    Myung JH; Roengvoraphoj M; Tam KA; Ma T; Memoli VA; Dmitrovsky E; Freemantle SJ; Hong S
    Anal Chem; 2015 Oct; 87(19):10096-102. PubMed ID: 26312815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
    Wei T; Zhu D; Yang Y; Yuan G; Xie H; Shen R
    PLoS One; 2019; 14(7):e0219129. PubMed ID: 31344053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fiber-Optic Array Scanning Technology (FAST) for Detection and Molecular Characterization of Circulating Tumor Cells.
    Ao Z; Liu X
    Methods Mol Biol; 2017; 1634():235-246. PubMed ID: 28819856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.